Related Experiment Videos
Histogenesis of ovarian malignant mixed mesodermal tumours
1Department of Histopathology, Derriford Hospital, Plymouth.
Journal of Clinical Pathology
|April 1, 1990
Summary
Ovarian malignant mixed mesodermal tumors are not metaplastic carcinomas. Our study found no evidence of transition from carcinoma to sarcoma, suggesting distinct origins for these tumor components.
Area of Science:
- Gynecologic Oncology
- Pathology
- Tumor Biology
Background:
- The origin of ovarian malignant mixed mesodermal tumors (OMMTs) is debated, with metaplastic carcinoma being a proposed theory.
- Understanding the histogenesis of OMMTs is crucial for accurate diagnosis and treatment strategies.
Purpose of the Study:
- To investigate the histogenesis of ovarian malignant mixed mesodermal tumors.
- To determine if OMMTs arise from metaplastic transition of carcinoma to sarcoma.
Main Methods:
- Morphological and reticulin staining were used to examine four OMMT cases.
- Immunohistochemistry for cytokeratin and vimentin was performed on consecutive sections.
- Cells at the carcinoma-sarcoma interface were analyzed for co-expression of markers.
Main Results:
- No morphological or architectural evidence of transition from carcinoma to sarcoma was observed.
- Immunohistochemical analysis showed no cells co-expressing cytokeratin and vimentin at the interface.
- The findings indicate distinct cellular origins rather than a metaplastic process.
Conclusions:
- Ovarian malignant mixed mesodermal tumors are likely not metaplastic carcinomas.
- These tumors appear to originate from histogenetically distinct cellular elements.
- Further research into the specific origins of each component is warranted.